BROMODOMAIN-CONTAINING PROTEIN 4

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 18:33:08 GMT 2025` Edited by `admin` on `Tue Apr 01 18:33:08 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	ROBCL9VI3C
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HUNK1

Preferred Name

English

BROMODOMAIN-CONTAINING PROTEIN 4

Common Name

English

BRD4

Common Name

English

PROTEIN HUNK1

Common Name

English

Code System Code Type Description

UNIPROT

O60885

Created by admin on Tue Apr 01 18:33:08 GMT 2025 , Edited by admin on Tue Apr 01 18:33:08 GMT 2025

PRIMARY

FDA UNII

ROBCL9VI3C

Created by admin on Tue Apr 01 18:33:08 GMT 2025 , Edited by admin on Tue Apr 01 18:33:08 GMT 2025

PRIMARY

Related Record Type Details


					X8BW0MQ5PI

Ezobresib

INHIBITOR -> TARGET

Amount:


					C7C7U6YEAO

AZD-5153

INHIBITOR -> TARGET


					W758F1L9ND

PLX-51107

INHIBITOR -> TARGET


					O28XHZ9UQ4

ZEN-3694

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					X40LKS49S3

BIRABRESIB

INHIBITOR -> TARGET


					ROBCL9VI3C

BROMODOMAIN-CONTAINING PROTEIN 4

INHIBITOR -> TARGET

Comments:

Suppressed gene expression of VI mediators in monocytes and endothelial cells by inhibiting BET-dependent transcription induced by multiple inflammatory stimuli. In CVD patients, apabetalone treatment reduced circulating levels of VI mediators, an outcome conducive with atherosclerotic plaque stabilization and MACE reduction.

Qualification:

IC50

Amount:


					U4017GUQ06

PELABRESIB ANHYDROUS

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					F6XR3O34V2

AMREDOBRESIB

INHIBITOR -> TARGET

Comments:

INHIBITS BRD4(BD2) BINDING TO ACETYLATED HISTONES

Qualification:

IC50

Amount:


					5QIO6SRZ2R

MOLIBRESIB

INHIBITOR -> TARGET

Amount:


					9MX546E2SF

ABBV-744

INHIBITOR -> TARGET

Comments:

A >250x differential binding preference for BDII over BDI


					8R4A7GDZ1D

APABETALONE

INHIBITOR -> TARGET


					M9ALI41OQR

BAY-1238097

INHIBITOR -> TARGET

Amount:


					1MRH0IMX0W

JQ1

INHIBITOR -> TARGET

Structural Modifications

Modification Type	Location Site	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_470] [1_601] [1_1117]	DEXFOSFOSERINE	VI4F0K069V
AMINO ACID SUBSTITUTION	[1_1111]	N6-ACETYLLYSINE	470AD5VY1X
AMINO ACID SUBSTITUTION	[1_484] [1_488] [1_492] [1_494] [1_498] [1_499] [1_503]	DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL